These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15329503)

  • 1. Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device.
    Maejima Y; Yasu T; Kubo N; Kawahito K; Omura N; Katsuki T; Tsukamoto Y; Sugawara Y; Hashimoto S; Tsuruya Y; Hirahara T; Takagi Y; Kobayashi N; Funayama H; Ikeda N; Ishida T; Fujii M; Ino T; Saito M
    Circ J; 2004 Sep; 68(9):829-33. PubMed ID: 15329503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up on cardiac function following fulminant myocarditis requiring percutaneous extracorporeal cardiopulmonary support.
    Ishida K; Wada H; Sakakura K; Kubo N; Ikeda N; Sugawara Y; Ako J; Momomura S
    Heart Vessels; 2013 Jan; 28(1):86-90. PubMed ID: 22203407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant myocarditis treated with percutaneous cardiopulmonary support system (PCPS).
    Oshima K; Kunimoto F; Hinohara H; Hayashi Y; Hirato J; Tajima Y; Kuwano H
    Ann Thorac Cardiovasc Surg; 2008 Apr; 14(2):75-80. PubMed ID: 18414343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee).
    Aoyama N; Izumi T; Hiramori K; Isobe M; Kawana M; Hiroe M; Hishida H; Kitaura Y; Imaizumi T;
    Circ J; 2002 Feb; 66(2):133-44. PubMed ID: 11999637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of echocardiographic monitoring in percutaneous cardiopulmonary support for the treatment of acute fulminant myocarditis: report of one case].
    Wang P; Xie ZB; Wu W
    Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):602-3. PubMed ID: 15151848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful management of a man with fulminant myocarditis using percutaneous cardiopulmonary support].
    Ohkawa M; Nishikawa K; Takazawa T; Hinohara H; Kunimoto F; Goto F
    Masui; 2005 Feb; 54(2):172-6. PubMed ID: 15747516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of fulminant myocarditis with mechanical circulatory support.
    Furukawa N; Hata M; Sezai A; Niino T; Yoda M; Unosawa S; Minami K
    J Card Surg; 2008; 23(5):570-2. PubMed ID: 18355222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis.
    Ammirati E; Cipriani M; Lilliu M; Sormani P; Varrenti M; Raineri C; Petrella D; Garascia A; Pedrotti P; Roghi A; Bonacina E; Moreo A; Bottiroli M; Gagliardone MP; Mondino M; Ghio S; Totaro R; Turazza FM; Russo CF; Oliva F; Camici PG; Frigerio M
    Circulation; 2017 Aug; 136(6):529-545. PubMed ID: 28576783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of cytokines and neurohumoral factors in a case of fulminant myocarditis successfully treated with intravenous immunoglobulin and percutaneous cardiopulmonary support.
    Abe S; Okura Y; Hoyano M; Kazama R; Watanabe S; Ozawa T; Saigawa T; Hayashi M; Yoshida T; Tachikawa H; Kashimura T; Suzuki K; Nagahashi M; Watanabe J; Shimada K; Hasegawa G; Kato K; Hanawa H; Kodama M; Aizawa Y
    Circ J; 2004 Dec; 68(12):1223-6. PubMed ID: 15564712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fulminant myocarditis treated with percutaneous cardiopulmonary support and long-term complications: three case reports].
    Kusaba T; Nakahara Y; Matsumuro A; Nakamura T; Sawada S
    J Cardiol; 2004 Apr; 43(4):185-91. PubMed ID: 15125383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long term prognosis of fulminant myocarditis and predictors related to impaired cardiac function post discharge].
    Jiang JG; Liu C; Cui GL; Chen C; Zuo HJ; Li R; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):263-269. PubMed ID: 35340145
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful management of fulminant myocarditis with left ventricular assist device: report of a severe case.
    Unosawa S; Hata M; Sezai A; Niino T; Yoshitake I; Shimura K; Takamori T; Minami K
    Ann Thorac Cardiovasc Surg; 2010 Aug; 16(1):48-51. PubMed ID: 20190711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors for weaning from a percutaneous cardiopulmonary support system (PCPS) in patients with severe cardiac failure: a comparative study in weaned and nonweaned patients.
    Oshima K; Morishita Y; Hinohara H; Hayashi Y; Tajima Y; Kunimoto F
    Int Heart J; 2006 Jul; 47(4):575-84. PubMed ID: 16960412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acutely severe myocarditis successfully treated by percutaneous cardiopulmonary support applied by a newly developed heparin-binding oxygenator and circuits.
    Yasu T; Murata S; Katsuki T; Fujii M; Kubo N; Ohmura N; Ino T; Saito M
    Jpn Circ J; 1997 Dec; 61(12):1037-42. PubMed ID: 9412869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive score for survival after percutaneous cardiopulmonary support in cardiovascular disease patients- evaluation of pre-procedural information.
    Shirakabe A; Nozaki A; Hata N; Kobayashi N; Shinada T; Tomita K; Tsurumi M; Matsushita M; Okazaki H; Yamamoto Y; Yokoyama S; Asai K; Mizuno K
    Circ J; 2013; 77(8):2064-72. PubMed ID: 23615051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of fulminant myocarditis successfully treated by percutaneous cardiopulmonary support after 50 minuite-cardiopulmonary resuscitation].
    Asano M; Soen M; Doi Y; Kishi K; Okumura K; Mori Y; Nemoto S; Hayashi M; Umegaki O; Minami T
    Masui; 2013 Feb; 62(2):178-82. PubMed ID: 23479919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of a giant cell myocarditis that developed massive left ventricular thrombus during percutaneous cardiopulmonary support.
    Takei Y; Ejima Y; Toyama H; Takei K; Ota T; Yamauchi M
    JA Clin Rep; 2016; 2(1):41. PubMed ID: 29492436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of influenza subtype A virus-induced fulminant myocarditis: an experience of percutaneous cardio-pulmonary support (PCPS) treatment and immunohistochemical analysis.
    Miura M; Asaumi Y; Wada Y; Ogata K; Sato T; Sugawara T; Yano M; Mitsu-Oka M; Takai O; Ota K; Namiki K; Sato D; Sato E; Nagura H; Kimura T
    Tohoku J Exp Med; 2001 Sep; 195(1):11-9. PubMed ID: 11780720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors and values at admission that predict a fulminant course of acute myocarditis: data from Tokyo CCU network database.
    Inaba O; Satoh Y; Isobe M; Yamamoto T; Nagao K; Takayama M
    Heart Vessels; 2017 Aug; 32(8):952-959. PubMed ID: 28255801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress.
    Kishimoto C; Shioji K; Kinoshita M; Iwase T; Tamaki S; Fujii M; Murashige A; Maruhashi H; Takeda S; Nonogi H; Hashimoto T
    Int J Cardiol; 2003 Oct; 91(2-3):173-8. PubMed ID: 14559127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.